Cargando…

Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study

To compare the relationship between background parenchymal enhancement (BPE) on contrast-enhanced spectral mammography (CESM), mammographic breast density (MBD), age, in the group with benign vs malignant breast lesions. Four hundred thirty three non-high-risk patients from January 2018 to May 2019...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Liangliang, Wang, Yongtao, Xing, Dong, Gong, Peiyou, Chen, Qianqian, Lv, Yongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769306/
https://www.ncbi.nlm.nih.gov/pubmed/33350778
http://dx.doi.org/10.1097/MD.0000000000023857
_version_ 1783629295084634112
author Yu, Liangliang
Wang, Yongtao
Xing, Dong
Gong, Peiyou
Chen, Qianqian
Lv, Yongbin
author_facet Yu, Liangliang
Wang, Yongtao
Xing, Dong
Gong, Peiyou
Chen, Qianqian
Lv, Yongbin
author_sort Yu, Liangliang
collection PubMed
description To compare the relationship between background parenchymal enhancement (BPE) on contrast-enhanced spectral mammography (CESM), mammographic breast density (MBD), age, in the group with benign vs malignant breast lesions. Four hundred thirty three non-high-risk patients from January 2018 to May 2019 were retrospectively analyzed. Patients were assigned into 4 groups: premenopausal benign lesions, premenopausal malignant lesions, postmenopausal benign lesions, and postmenopausal malignant lesions. The differences in CESM BPE and MBD between premenopausal benign lesions and premenopausal malignant lesions, between postmenopausal benign lesions and postmenopausal malignant lesions, between premenopausal and postmenopausal benign lesions, and between premenopausal and postmenopausal malignant lesions were evaluated. Pearson Chi-Squared test was used to analyze the differences between the above groups. Spearman rank correlation analysis was used to evaluate the correlations between BPE, MBD, and age. Multiple logistic regression was used to analyze the influencing factors of breast cancer. P < .05 was considered statistically significant. There was no significant difference in CESM BPE or MBD of benign and malignant lesions regardless of premenopausal or postmenopausal status, but there was a significant difference in CESM BPE and MBD of premenopausal and postmenopausal patients regardless of the presence of benign or malignant lesions. The intensity of CESM BPE was positively correlated with MBD, and the intensity of CESM BPE and MBD were negatively correlated with age. Multiple logistic regression analysis showed that age was an influencing factor for breast cancer in both premenopausal and postmenopausal patients. For non-high-risk women, CESM BPE and MBD were not correlated with benign or malignant breast lesions, and age was an influencing factor for breast cancer.
format Online
Article
Text
id pubmed-7769306
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77693062020-12-29 Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study Yu, Liangliang Wang, Yongtao Xing, Dong Gong, Peiyou Chen, Qianqian Lv, Yongbin Medicine (Baltimore) 6800 To compare the relationship between background parenchymal enhancement (BPE) on contrast-enhanced spectral mammography (CESM), mammographic breast density (MBD), age, in the group with benign vs malignant breast lesions. Four hundred thirty three non-high-risk patients from January 2018 to May 2019 were retrospectively analyzed. Patients were assigned into 4 groups: premenopausal benign lesions, premenopausal malignant lesions, postmenopausal benign lesions, and postmenopausal malignant lesions. The differences in CESM BPE and MBD between premenopausal benign lesions and premenopausal malignant lesions, between postmenopausal benign lesions and postmenopausal malignant lesions, between premenopausal and postmenopausal benign lesions, and between premenopausal and postmenopausal malignant lesions were evaluated. Pearson Chi-Squared test was used to analyze the differences between the above groups. Spearman rank correlation analysis was used to evaluate the correlations between BPE, MBD, and age. Multiple logistic regression was used to analyze the influencing factors of breast cancer. P < .05 was considered statistically significant. There was no significant difference in CESM BPE or MBD of benign and malignant lesions regardless of premenopausal or postmenopausal status, but there was a significant difference in CESM BPE and MBD of premenopausal and postmenopausal patients regardless of the presence of benign or malignant lesions. The intensity of CESM BPE was positively correlated with MBD, and the intensity of CESM BPE and MBD were negatively correlated with age. Multiple logistic regression analysis showed that age was an influencing factor for breast cancer in both premenopausal and postmenopausal patients. For non-high-risk women, CESM BPE and MBD were not correlated with benign or malignant breast lesions, and age was an influencing factor for breast cancer. Lippincott Williams & Wilkins 2020-12-24 /pmc/articles/PMC7769306/ /pubmed/33350778 http://dx.doi.org/10.1097/MD.0000000000023857 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 6800
Yu, Liangliang
Wang, Yongtao
Xing, Dong
Gong, Peiyou
Chen, Qianqian
Lv, Yongbin
Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study
title Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study
title_full Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study
title_fullStr Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study
title_full_unstemmed Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study
title_short Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study
title_sort background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: a preliminary study
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769306/
https://www.ncbi.nlm.nih.gov/pubmed/33350778
http://dx.doi.org/10.1097/MD.0000000000023857
work_keys_str_mv AT yuliangliang backgroundparenchymalenhancementoncontrastenhancedspectralmammographydoesnotrepresentaninfluencingfactorforbreastcancerapreliminarystudy
AT wangyongtao backgroundparenchymalenhancementoncontrastenhancedspectralmammographydoesnotrepresentaninfluencingfactorforbreastcancerapreliminarystudy
AT xingdong backgroundparenchymalenhancementoncontrastenhancedspectralmammographydoesnotrepresentaninfluencingfactorforbreastcancerapreliminarystudy
AT gongpeiyou backgroundparenchymalenhancementoncontrastenhancedspectralmammographydoesnotrepresentaninfluencingfactorforbreastcancerapreliminarystudy
AT chenqianqian backgroundparenchymalenhancementoncontrastenhancedspectralmammographydoesnotrepresentaninfluencingfactorforbreastcancerapreliminarystudy
AT lvyongbin backgroundparenchymalenhancementoncontrastenhancedspectralmammographydoesnotrepresentaninfluencingfactorforbreastcancerapreliminarystudy